samarium has been researched along with Blood Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Douard, MC; George, B; Rain, JD | 1 |
| Anderson, PM; Arndt, CA; Bruland, OS; Dispenzieri, A; Hartmann, LC; Mullan, BP; Smithson, WA; Wiseman, GA | 1 |
1 review(s) available for samarium and Blood Diseases
| Article | Year |
|---|---|
[Metabolic radiotherapy: what role will it have in 2001?].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Analgesics, Opioid; Bone Neoplasms; Clinical Trials as Topic; Double-Blind Method; Forecasting; France; Hematologic Diseases; Humans; Male; Middle Aged; Organometallic Compounds; Organophosphorus Compounds; Pain; Palliative Care; Phosphorus Radioisotopes; Prospective Studies; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Rhenium; Samarium; Strontium; Strontium Radioisotopes; Treatment Outcome | 2002 |
1 other study(ies) available for samarium and Blood Diseases
| Article | Year |
|---|---|
High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Dose-Response Relationship, Drug; Hematologic Diseases; Humans; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Organometallic Compounds; Organophosphorus Compounds; Osteosarcoma; Palliative Care; Radioisotopes; Samarium; Tissue Distribution | 2002 |